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Abstract
Taking into consideration that the immune response following infection promotes the expansion of lymphocyte clones that are essentially
non-speci®c, ensuring both parasite evasion and persistence inside the host, what would be the major consequences of this polyclonal
response to the development of immunopathology? We favor the hypothesis that the polyclonal B cell responses triggered by the infection is
responsible of the host susceptibility and is a major contributor to the maintenance of a progressive disease. In particular, the activation of B
cells by parasite mitogens would contribute to the class determination of T cell responses and to the inhibition of macrophages - target cells
for parasite multiplication and also responsible for parasite clearance. We also envisage that the activation of T cells by parasite `super-
antigens', and the ensuing energy and deletion of these cells, processes that are frequently observed, would contribute for the immunosup-
pression as well as to parasite escape and persistence in the host. We had concentrated our efforts on the study of the non-speci®c aspects of
the immune response following Trypanosoma cruzi infection. We aimed at ®nding new strategies to modulate and control the mechanisms
leading to both the immunosuppression and the development of chronic auto-immunity leading to rational vaccine approaches against
parasite infection and immunopathology. q 2001 Australian Society for Parasitology Inc. Published by Elsevier Science Ltd. All rights
reserved.
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1. Rationale
We had previously shown that the main characteristic of
the mouse and human infections with T. cruzi is the induc-
tion of a massive lymphocyte polyclonal activation invol-
ving all major and minor lymphocyte B and T cell subsets
(Minoprio et al., 1986a,b). We had con®rmed that B- and T-
cell activation is indeed polyclonal by the molecular analy-
sis of B (BCR) and T (TCR) cell repertoires (Leite de
Moraes et al., 1994; Minoprio et al., 1989a). An important
feature of this response is the preferential activation of
CD5 1 B and gd 1 T cells (Minoprio et al., 1989b,c).
These cells, closely related in ontogeny are associated
with auto-immune disorders (Marcos et al., 1988).
A major and dramatic aspect of Chagas disease is the
development of chronic active myocarditis after a prolonged
asymptomatic infection. Studies in human and experimental
models highlight the importance of auto-immune mechan-
isms in the pathogenesis of Chagas disease. Additionally,
the `panclonal' activation described above is responsible for
the hypergammaglobulinemia observed during the acute
and chronic phases of the disease. We showed that the B
cells activated by the infection are in their great majority
(98%) responsible for the production of antibodies that lack
parasite speci®city, in agreement with the polyclonal nature
of the B cell response (Minoprio et al., 1988). It would also
seem that B and T cell polyclonal activation following
T. cruzi infection are at the origin of the humoral and cellu-
lar immunosuppression towards homologous and heterolo-
gous antigens (Minoprio et al., 1989c). Furthermore, the B
cell polyclonal activation following the infection includes
the expansion of auto-reactive B cell clones that may play a
key role in the physiopathology of the infection and can be
involved in late developing auto-immunity (Minoprio et al.,
1988; Spinella et al., 1990). Thus it is frequently hypothe-
sised that auto-immunity arises from cross-reactivity
between host and parasite antigens or from the expansion
of anti-self clones generated during non-speci®c polyclonal
activation of the immune system (Eisen and Kahn 1991;
Ribeiro-dos-Santos and Pirmez, 1991). However, the devel-
opment of auto-immune tissue damage in late phases of
Chagas disease may well result from a combination of poly-
clonal (non-speci®c) and parasite-directed (speci®c)
immune responses (Reina-San-Martin et al., 2000a; Tarle-
ton et al., 1997).
We believe that the non-speci®c polyclonal activation of
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antigens may play an important role in the precocious
phases of infection by enlarging the repertoire of B and T
cells reacting, for instance, to `self' molecules and thus
contributing to tissue damage. We cannot rule out the
expansion of lymphocyte clones that are speci®cally direc-
ted against parasite antigens that are also able to cross react
with host molecules, i.e. `self' (molecular mimicry). This
hypothesis, although not excluding the polyclonality of the
immune response and its consequences, would have a
distinct and signi®cant additional effect on the breakdown
of tolerance to self antigens and allow the development of
organ-speci®c auto-immunity in the chronic phases of infec-
tion. In Chagas disease, heart auto-immune pathology
results from a progressive and time-dependent destruction
of cardiocytes culminating in myocardium failure, thus the
analysis of the immune mechanisms involved with the trig-
gering of auto-immunity is very attractive and deserves
attention.
2. Polyclonal activation is a general immunological
feature following the infectious process
Mitogens and superantigens have been described to
explain the strategy used by micro-organisms to avoid the
host speci®c immune responses and to ensure persistence.
These moieties are responsible for the initiation of non-
speci®c (polyclonal) immune responses. The importance
of polyclonal responses following infections can be evalu-
ated by the degree of disturbances presented by the infected
host, namely splenomegaly, adenopathy, immunosuppres-
sion, toxic shock syndromes, granuloma formation, progres-
sive auto-immunity.
The complex antigenic composition of micro-organisms
might be thought as the main cause of the hyperstimulation
of the immune system thus leading to the expansion of
lymphocyte clones speci®cally directed to the multitude of
challenging antigens. However, a better control of infection
should then be expected in the initial phases of infection.
Instead, the molecular and functional analysis of B- and T-
cell repertoires have indeed shown that the indiscriminate
utilisation of B- and T- cell genes encoding BCR and TCR is
incompatible with oligoclonal responses. We have then
proposed that the dif®culties faced by the immune system
to eliminate micro-organisms may rely on the fact that para-
sites, viruses, bacteria and fungi trigger non-speci®c poly-
clonal B- and T- lymphocyte responses and ensuring
evasion through avoiding ef®cient control of the beginning
of the infection. We have summarised the major alterations
of the immune system functions following the infectious
process and considered new alternatives for vaccination
approaches (Reina-San-Martin et al., 2000a). We took into
account that classical vaccination approaches have focused
on the study of `immunodominant' or `immunopathologi-
cal' epitopes, and that the great majority of the immunolo-
gically relevant interactions occurring after infection are not
limited to speci®c immune responses to these epitopes. We
have then proposed that a better goal to provoke immunity
should necessarily include: (a) Studies to elucidate of the
mechanisms used by micro-organisms to trigger polyclonal
responses, (b) Isolation of the moieties responsible for this
triggering and (c) Neutralisation of these molecules and
activities in the host or their inactivation in the micro-organ-
ism.
3. A B-cell mitogen of T. cruzi is the ®rst eukaryotic
proline-racemase
We have previously shown that the abrogation or reduc-
tion of polyclonal lymphocyte activation leads to an
increased resistance to T. cruzi infection (Minoprio et al.,
1991, 1987; Santos-Lima and Minoprio 1996; Santos-Lima
et al., 2001). Given that the parasite can release B cell
mitogenic proteins (Cordeiro da Silva et al., 1998; Montes
et al., 1999), we looked for new molecules secreted by
metacyclic infective forms that could be responsible for
such a mechanism of immune evasion.
Using biochemical and molecular approaches we isolated
from culture supernatants of T. cruzi cultures, a parasite
protein (TcPA45) involved in the polyclonal activation of
B lymphocytes (Reina-San-Martin et al., 2000b). We
obtained the full sequence of the gene encoding TcPA45
and its ¯anking regions. By the analysis of the genomic
organisation and transcription of the Tc45 gene we showed
the presence of two gene copies per haploid genome and
that Tc45 mRNA is present in the different parasite forms.
By immuno¯uorescence and western blotting we showed
that the parasite can differentially express intracellular and
secreted forms of the TcPA45 protein. The analysis of the
Tc45 gene revealed the presence of a signal peptide indicat-
ing active secretion by T. cruzi. Interestingly, we found an
alternative trans-splicing signal about 170 bp upstream of a
second ATG codon within the coding region that suggests
that, if used, would allow for the expression of a truncated
protein lacking 69 amino acids that would not be secreted.
In fact, we detected a isoform of the TcPA45 protein of
around 39 kDa in epimastigote (non-infective) form of the
parasite and a 41.5 kDa protein in infective metacyclic
forms. The computer analyses of the TcPA45 sequence
indeed predicted Mr of 43.4 and 39 kDa for a secreted
and a non-secreted form of the protein.
The comparison of the nucleotide and peptide sequences
of TcPA45 with several data bases revealed a striking
homology with the only proline racemase described, an
homodimeric protein isolated from Clostridium sticklandii.
This enzyme catalyses the interconversion of L- and D-
proline enantiomers. The active site of the bacterial proline
racemase was previously identi®ed and is conserved in the
TcPA45 protein. We then produced a recombinant TcPA45
protein by overexpressing the gene in E. coli. By in vitro and
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indeed a T- cell independent B- cell mitogen. By biochem-
ical assays we also showed that TcPA45 is indeed a proline
racemase that racemises both L- and D- proline and not any
other amino acid. Furthermore, the TcPA45 mitogenic
activity is abolished, or severely compromised whenever
enzymatic activity is inhibited by speci®c inhibitors or
substrates (L- or D- proline). We presented evidences for
the linkage of both activities of TcPA45 and showed that the
integrity of the enzyme active site is necessary to allow
mitogenicity.
To our knowledge, this is the ®rst report of a eukaryotic
amino acid racemase gene. The implications of our ®ndings
to T. cruzi biology and pathogenicity, as well as to the
possible role of D- amino acids in immune phenomena
were discussed in our paper (Reina-San-Martin et al.,
2000b).
4. Towards new vaccination approaches
There is no effective treatment or vaccine against T. cruzi
infection and its consequent pathology. In order to validate
our hypothesis that the reduction of immune activities could
lead to a re-orientation of the immune system and conse-
quently to a better control of infection we tried to use
TcPA45 for immune intervention. Our aim was to induce
speci®c responses against TcPA45 and neutralise its mito-
genic activity.
In one of the protocols we used intramuscular DNA
`vaccination' containing the TcPA45 gene. We showed
that `immunoprotection' is certainly possible, as we
obtained 85% decrease in parasitaemia levels after chal-
lenge with infective forms of the parasite. Moreover, even
higher levels of parasitaemia control have been observed
when sub-mitogenic doses of the protein were injected.
Thus, speci®c B cell responses against mitogens is possible
if low (`antigenic') doses of mitogens are used (Coutinho et
al., 1974). We observed that the i.p. injection of low doses of
rTcPA45 protein was able to decrease up to 95% the para-
sitaemia of mice after challenge with a lethal inoculum of T.
cruzi. We showed that both protocols of immunisation were
able to trigger speci®c B cells and high levels of antibodies
anti-rTcPA45 were detected in sera.
These preliminary results suggest that mitogenic proteins
can be used as `vaccines' or `drug targets': neutralisation of
these proteins could abort this particular parasite strategy
that seeks to deviate immune responses into a non-speci®c
activation on the immune system and immunosuppression.
A better and systematic comprehension of common
mechanisms used by microorganisms to induce polyclonal
activation, such that microbes can evade and persist in the
host may open the way to new vaccination and therapeutics
strategies. Our work may stimulate further research on the
biological role of mitogenic molecules and their implica-
tions in immune phenomena.
5. Summary
Our goal is to elucidate the events that trigger polyclonal
activation of lymphocytes and contribute to autoimmune
chronic pathology which is characteristic of Chagas disease.
In so doing we may reveal general principles involved in the
development of autoimmunity following infections. We will
determine if both polyclonal and oligoclonal parasite-
induced immune responses of speci®c lymphocyte popula-
tions are needed for the establishment of pathology. We aim
to identify the parasite molecules responsible for this
process. This study will improve our knowledge of the inter-
actions of the host's immune system with the parasite and
may lead to a rational strategy to prevent the development of
autoimmunity in general.
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